Your browser doesn't support javascript.
loading
Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study.
Declercq, Pierre-Louis; Fournel, Isabelle; Demeyere, Matthieu; Berraies, Anissa; Ksiazek, Eléa; Nyunga, Martine; Daubin, Cédric; Ampere, Alexandre; Sauneuf, Bertrand; Badie, Julio; Delbove, Agathe; Nseir, Saad; Artaud-Macari, Elise; Bironneau, Vanessa; Ramakers, Michel; Maizel, Julien; Miailhe, Arnaud-Felix; Lacombe, Béatrice; Delberghe, Nicolas; Oulehri, Walid; Georges, Hugues; Tchenio, Xavier; Clarot, Caroline; Redureau, Elise; Bourdin, Gaël; Federici, Laura; Adda, Mélanie; Schnell, David; Bousta, Mehdi; Salmon-Gandonnière, Charlotte; Vanderlinden, Thierry; Plantefeve, Gaëtan; Delacour, David; Delpierre, Cyrille; Le Bouar, Gurvan; Sedillot, Nicholas; Beduneau, Gaëtan; Rivière, Antoine; Meunier-Beillard, Nicolas; Gélinotte, Stéphanie; Rigaud, Jean-Philippe; Labruyère, Marie; Georges, Marjolaine; Binquet, Christine; Quenot, Jean-Pierre.
Affiliation
  • Declercq PL; Service de Médecine Intensive Réanimation, CH de Dieppe, Dieppe, France.
  • Fournel I; Centre d'Investigation Clinique, CHU Dijon, Dijon, France.
  • Demeyere M; INSERM, CIC 1432, Module Epidémiologie Clinique, Dijon, France.
  • Berraies A; Service de Radiologie, CHU Rouen, 76000, Rouen, France.
  • Ksiazek E; Service de Pneumologie, CH Chartres, Chartres, France.
  • Nyunga M; Centre d'Investigation Clinique, CHU Dijon, Dijon, France.
  • Daubin C; INSERM, CIC 1432, Module Epidémiologie Clinique, Dijon, France.
  • Ampere A; Service de Médecine Intensive Réanimation, CH de Roubaix, Roubaix, France.
  • Sauneuf B; Department of Medical Intensive Care, CHU de Caen Normandie, Caen, France.
  • Badie J; Service de Pneumologie, CH de Béthune, Béthune, France.
  • Delbove A; Service de Médecine Intensive Réanimation, CH Public du Cotentin, Cherbourg-en-Cotentin, France.
  • Nseir S; Service de Médecine Intensive Réanimation, Hopital Nord Franche-Comte, Trevenans, France.
  • Artaud-Macari E; Service de Réanimation Polyvalente, CHBA Vannes, Vannes, France.
  • Bironneau V; Service de Médecine Intensive Réanimation, CHRU Roger Salengro, Lille, France.
  • Ramakers M; Inserm U1285, Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, Lille, France.
  • Maizel J; University of Normandie, UNIROUEN, EA3830, CHU Rouen, Department of Pneumology, Thoracic Oncology and Respiratory Intensive Care Unit, Rouen, France.
  • Miailhe AF; Service de Pneumologie, CHU Poitiers, Poitiers, France.
  • Lacombe B; INSERM CIC 1402, ALIVES Research Group, Université de Poitiers, Poitiers, France.
  • Delberghe N; Service de Médecine Intensive Réanimation, Centre Hospitalier Mémorial de Saint-Lô, Saint-Lô, France.
  • Oulehri W; Service de Médecine Intensive Réanimation, CHU d'Amiens, Amiens, France.
  • Georges H; Service de Médecine Intensive Réanimation, CHU Nantes, Nantes, France.
  • Tchenio X; Service de Réanimation Polyvalente, Groupe Hospitalier Bretagne Sud, Lorient, France.
  • Clarot C; Service de Pneumologie, CHES Evreux, Évreux, France.
  • Redureau E; Service de Réanimation Chirurgicale, CHRU Strasbourg, Strasbourg, France.
  • Bourdin G; Service de Médecine Intensive Réanimation, CH de Tourcoing, Tourcoing, France.
  • Federici L; Service de Réanimation Polyvalente, Centre Hospitalier Fleyriat, Bourg en Bresse, France.
  • Adda M; Service de Pneumologie, CH d'Abbeville, Abbeville, France.
  • Schnell D; Service de Pneumologie, CHD Vendée, La Roche-sur-Yon, France.
  • Bousta M; Service de Réanimation Polyvalente, CH Saint Joseph Saint Luc, Lyon, France.
  • Salmon-Gandonnière C; Service de Médecine Intensive Réanimation, AP-HP, Hôpital Louis Mourier, Colombes, France.
  • Vanderlinden T; Service de Médecine Intensive Réanimation, Hôpitaux de Marseille, Hôpital Nord, Marseille, France.
  • Plantefeve G; Service de Réanimation Polyvalente et USC, CH d'Angoulême, Angoulême, France.
  • Delacour D; Service de Réanimation Médico-Chirugicale, Groupe Hospitalier du Havre, Le Havre, France.
  • Delpierre C; Service de Médecine Intensive Réanimation, CHRU de Tours, Tours, France.
  • Le Bouar G; Intensive Care Unit, St Philibert hospital, ETHICS EA 7446, Lille Catholic University, Lille, France.
  • Sedillot N; Service de Médecine Intensive Réanimation, CH d'Argenteuil, Argenteuil, France.
  • Beduneau G; Service de radiologie, Clinique du Cèdre, Bois-Guillaume, France.
  • Rivière A; CERPOP, Université de Toulouse, Inserm, Toulouse, France.
  • Meunier-Beillard N; Service de Médecine Intensive Réanimation, CHES Evreux, Evreux, France.
  • Gélinotte S; Service de Réanimation Polyvalente, Centre Hospitalier Fleyriat, Bourg en Bresse, France.
  • Rigaud JP; Normandie Univ, UNIROUEN, UR3830, CHU Rouen, Department of Medical Intensive Care, 76000, Rouen, France.
  • Labruyère M; Service de Réanimation Polyvalente, CH d'Abbeville, Abbeville, France.
  • Georges M; Centre d'Investigation Clinique, CHU Dijon, Dijon, France.
  • Binquet C; INSERM, CIC 1432, Module Epidémiologie Clinique, Dijon, France.
  • Quenot JP; Service de Médecine Intensive Réanimation, CH de Dieppe, Dieppe, France.
Intensive Care Med ; 49(10): 1168-1180, 2023 10.
Article in En | MEDLINE | ID: mdl-37620561
ABSTRACT

PURPOSE:

Survivors after acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19) are at high risk of developing respiratory sequelae and functional impairment. The healthcare crisis caused by the pandemic hit socially disadvantaged populations. We aimed to evaluate the influence of socio-economic status on respiratory sequelae after COVID-19 ARDS.

METHODS:

We carried out a prospective multicenter study in 30 French intensive care units (ICUs), where ARDS survivors were pre-enrolled if they fulfilled the Berlin ARDS criteria. For patients receiving high flow oxygen therapy, a flow ≥ 50 l/min and an FiO2 ≥ 50% were required for enrollment. Socio-economic deprivation was defined by an EPICES (Evaluation de la Précarité et des Inégalités de santé dans les Centres d'Examens de Santé - Evaluation of Deprivation and Inequalities in Health Examination Centres) score ≥ 30.17 and patients were included if they performed the 6-month evaluation. The primary outcome was respiratory sequelae 6 months after ICU discharge, defined by at least one of the following criteria forced vital capacity < 80% of theoretical value, diffusing capacity of the lung for carbon monoxide < 80% of theoretical value, oxygen desaturation during a 6-min walk test and fibrotic-like findings on chest computed tomography.

RESULTS:

Among 401 analyzable patients, 160 (40%) were socio-economically deprived and 241 (60%) non-deprived; 319 (80%) patients had respiratory sequelae 6 months after ICU discharge (81% vs 78%, deprived vs non-deprived, respectively). No significant effect of socio-economic status was identified on lung sequelae (odds ratio (OR), 1.19 [95% confidence interval (CI), 0.72-1.97]), even after adjustment for age, sex, most invasive respiratory support, obesity, most severe P/F ratio (adjusted OR, 1.02 [95% CI 0.57-1.83]).

CONCLUSIONS:

In COVID-19 ARDS survivors, socio-economic status had no significant influence on respiratory sequelae 6 months after ICU discharge.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article